Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $75.8800 (2%) ($75.8800 - $75.8800) on Mon. Apr. 17, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.82% (three month average) | RSI | 62 | Latest Price | $75.8800(2%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND advances 0.7% a day on average for past five trading days. | Weekly Trend | LGND advances 1.8% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) XBI(53%) IWM(50%) IWN(50%) IWC(49%) IBB(48%) | Factors Impacting LGND price | LGND will decline at least -1.41% in a week (0% probabilities). VXX(-20%) VIXM(-16%) UUP(-14%) SMH(-12%) SHY(-11%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.41% (StdDev 2.82%) | Hourly BBV | 1 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $74.54(1.8%) | 10 Day Moving Average | $73.35(3.45%) | 20 Day Moving Average | $72.2(5.1%) | To recent high | -1.4% | To recent low | 12.7% | Market Cap | $1.219b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |